Physician profile
Andy Lee
NPI 1205047503
$1,435.45
in general payments reported to CMS, 2019-2025
10 companies · $684 in 2025
The $684 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $194 · 2021: $60.89 · 2022: $315 · 2023: $162 · 2024: $19.45 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846 · Education: $19.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $845.52 |
| Education | $19.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $477.14 | 2019-2022 | |
| Atricure, INC. | $348.40 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Becton, Dickinson and Company | $159.53 | 2025 | Hemosphere |
| Pacira Pharmaceuticals Incorporated | $157.87 | 2025 | Exparel |
| Fisher & Paykel Healthcare INC | $124.99 | 2023 | Fisher & Paykel Healthcare |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.85 | 2019 | |
| Merck Sharp & Dohme LLC | $55.09 | 2023-2025 | Bridion |
| Zimmer Biomet Holdings, INC. | $19.45 | 2024 | Persona |
| Acacia Pharma INC | $17.02 | 2022 | |
| Covidien Lp | $11.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andy Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.